Atara Biotherapeutics, Inc. (ATRA) vs MindWalk Holdings Corp. (HYFT)

A side-by-side comparison of Atara Biotherapeutics, Inc. and MindWalk Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATRA vs HYFT

growth of $100 · dividends reinvested · last 10y
ATRA -97.4% (-30.5%/yr)HYFT -66.0% (-10.2%/yr)HYFT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002019202120232025$3$34
ATRA HYFT

ATRA vs HYFT: by the numbers

  • •ATRA is the larger company ($85M vs $71M market cap).
  • •Both run net losses; HYFT's is the smaller (-105.29% vs -269.42% net margin).
  • •ATRA grew revenue faster over the past five years (56.10% vs -4.48% CAGR).

Metrics side by side

Valuation

MetricATRAHYFT
P/S ratio13.726.05
P/B ratioN/A14.39

Profitability

MetricATRAHYFT
Gross margin82.44%60.78%
Operating margin29.69%-96.01%
Net margin-269.42%-105.29%
ROEN/A-250.39%
ROIC-100.35%-153.46%

Growth (annualized)

MetricATRAHYFT
Revenue CAGR (5Y)56.10%-4.48%
Total return CAGR (5Y)-53.60%-23.93%

Frequently asked

Which has grown faster, ATRA or HYFT?
Over the past five years, ATRA grew revenue faster — ATRA at a 56.10% CAGR versus HYFT at -4.48%.
How have ATRA and HYFT total returns compared?
Over the past 5 years, ATRA delivered -53.60% and HYFT delivered -23.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.